Literature DB >> 8234169

Convective solvent flow across the skin during iontophoresis.

A Kim1, P G Green, G Rao, R H Guy.   

Abstract

Enhanced flux of neutral solutes during transdermal iontophoresis is attributed largely to electroosmotic volume flow. In this study, the iontophoretic fluxes of tritiated water (3H2O) and 14C-labeled mannitol through hairless mouse skin (HMS) were determined. The following questions were addressed: (i) What is the variability of water flux during iontophoresis? (ii) To what extent is the iontophoretic flux of a neutral solute correlated with water flux? (iii) Does the intrinsic permeability of the skin to neutral solutes change following iontophoresis? (iv) What is the effect of low pH on electroosmotic volume flow? and (v) Does the skin remain permselective after removal of the stratum corneum? Transport of both water and mannitol reached steady-state levels during 10 hr of constant-current iontophoresis (0.36 mA/cm2). Anodal fluxes exceeded cathodal values. Cathodal mannitol flux was retarded, relative to passive transport, by net volume flow in the opposite direction, such that transport of this molecule increased significantly after the termination of current passage. Anodal equivalent volume flows for water and mannitol, respectively, were 2.7 (+/- 1.3) and 1.23 (+/- 0.59) microL/hr cm2, indicating that only approximately 50% of the water flux participated in the electroosmosis of mannitol. The passive permeability of water and mannitol after 10 hr of iontophoresis was, respectively, 6 and 30 times greater than the pretreatment values. At pH 7, the cationic permselectivity of HMS was marginal [the Na+ transport number (tNa+) was determined to be 0.46] and less than that reported for human skin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234169     DOI: 10.1023/a:1018969713547

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Skin alteration and convective solvent flow effects during iontophoresis. II. Monovalent anion and cation transport across human skin.

Authors:  S M Sims; W I Higuchi; V Srinivasan
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin.

Authors:  R R Burnette; D Marrero
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

3.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

4.  DC electrical properties of frozen, excised human skin.

Authors:  G B Kasting; L A Bowman
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

5.  Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

6.  A new system for in vitro studies of iontophoresis.

Authors:  P Glikfeld; C Cullander; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

Review 7.  Transport phenomena in artificial membranes.

Authors:  N Lakshminarayanaiah
Journal:  Chem Rev       Date:  1965-10       Impact factor: 60.622

8.  Characterization of the permselective properties of excised human skin during iontophoresis.

Authors:  R R Burnette; B Ongpipattanakul
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

9.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

  9 in total
  19 in total

1.  Electroosmotic pore transport in human skin.

Authors:  Olivia D Uitto; Henry S White
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

2.  Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.

Authors:  Anne-Rose Denet; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

3.  Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring.

Authors:  Anke Sieg; Richard H Guy; M Begoña Delgado-Charro
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

4.  Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.

Authors:  R F Lopez; M V Bentley; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

5.  A programmable iontophoretic instrument and its application for local anesthesia before surgery in urology.

Authors:  Mahmut Tokmakçi; Oguz Ekmekçioglu; Mustafa Alçi
Journal:  J Med Syst       Date:  2005-04       Impact factor: 4.460

6.  Transdermal macromolecular delivery: real-time visualization of iontophoretic and chemically enhanced transport using two-photon excitation microscopy.

Authors:  B S Grewal; A Naik; W J Irwin; G Gooris; C J de Grauw; H G Gerritsen; J A Bouwstra
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

7.  The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis.

Authors:  N G Turner; Y N Kalia; R H Guy
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

8.  Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.

Authors:  P Santi; P Colombo; R Bettini; P L Catellani; A Minutello; N M Volpato
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

9.  Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery.

Authors:  S Laneri; A Sacchi; E A di Frassello; E Luraschi; P Colombo; P Santi
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

10.  Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models.

Authors:  A Luzardo-Alvarez; M Rodríguez-Fernández; J Blanco-Méndez; R H Guy; M B Delgado-Charro
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.